The aim of this study is to assess the role of AMH in prediction of poor ovarian response as
well as the relation between ESR2 (+1730G>A) (rs4986938), FSHR p.Thr307Ala (c.919A>G, rs6165)
and FSHR p.Asn680Ser (c.2039A>G, rs6166) SNPs and the poor response in Egyptian women
undergoing IVF procedure. Discovering the genetic variants associated with ovarian response
is an important step towards individualized pharmacogenetic protocols of ovarian stimulation.